Royal Bolton Hospital will help fulfil the final wish of Girls Aloud singer Sarah Harding to find new ways of spotting breast cancer early - when it's more treatable. Breast cancer is the leading cause of death in women aged 35-50 years in the UK, with an estimated 10,000 women a year diagnosed under the age of 50. Sarah, died from the disease aged 39 in 2021 and one of her final wishes was to find new ways of spotting breast cancer early, when it is more treatable.
Funded by The Christie Charity Sarah Harding Breast Cancer Appeal, phase two of the BCAN-RAY (Breast Cancer Risk Assessment in Younger Women) study will be rolled out to Royal Bolton Hospital which has been recognised as a centre of excellence in breast cancer care thanks to its use of new and innovative technologies. Dr Francis Andrews, Medical Director at Bolton NHS Foundation Trust said:“We’re really pleased that we will be able to recruit patients to this important study in just a few weeks. “As a research active trust, we are keen to reduce the devastating impact of breast cancer through recruiting as many younger women as possible to this trial.
” Other hospitals will also take part. The study will also involve the creation of a new medical role named in honour of Sarah who was treated at The Christie hospital in Manchester to oversee it. Phase one of the study found that dozens of young women have found out they are at increased risk of breast cancer.
Early results from the study show that 58 woman a.
_updates.jpg)
